Cytomx Therapeutics Inc (CTMX)

03:07 AM

What drives CytomX Therapeutics Inc. stock priceFree Stock Movement Tracking - Autocar Professional

03:07 AM

12:20 PM

CytomX Therapeutics Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com

12:20 PM

Jul 22, 2025

What analysts say about CytomX Therapeutics Inc. stockFree Trading Strategy Suggestions - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Is CytomX Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - Autocar Professional

Jul 20, 2025

Jul 16, 2025

Why CytomX Therapeutics Inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser

Jul 16, 2025

Jul 15, 2025

What makes CytomX Therapeutics Inc. stock price move sharplyFree Stock Selection - Newser

Jul 15, 2025

Jul 15, 2025

How CytomX Therapeutics Inc. stock performs during market volatilityProtected Capital Trading Plan - Newser

Jul 15, 2025

Jul 10, 2025

The Future of Allogene Therapeutics Inc: Analyzing ALLO - investchronicle.com

Jul 10, 2025

Jul 10, 2025

Pliant Therapeutics Inc (PLRX) Stock: Navigating a Year of Volatility - investchronicle.com

Jul 10, 2025

Jul 09, 2025

CTMX SEC FilingsCytomx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 09, 2025

Jul 06, 2025

Do CytomX Therapeutics' (NASDAQ:CTMX) Earnings Warrant Your Attention? - Yahoo Finance

Jul 06, 2025

Jul 03, 2025

CytomX Q2 2025 presentation slides: CX-2051 shows promising Phase 1 results in CRC By Investing.com - Investing.com South Africa

Jul 03, 2025

Jul 03, 2025

CytomX Q2 2025 presentation slides: CX-2051 shows promising Phase 1 results in CRC - Investing.com

Jul 03, 2025

Jun 25, 2025

Certain Pre-Funded warrants of CytomX Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 26-JUN-2025. - MarketScreener

Jun 25, 2025

Jun 17, 2025

CytomX Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView

Jun 17, 2025

Jun 17, 2025

CytomX Therapeutics CEO Sells Shares to Meet Tax Obligations - TradingView

Jun 17, 2025

Jun 13, 2025

CytomX Therapeutics Approves Key Amendments at Annual Meeting - TipRanks

Jun 13, 2025

Jun 13, 2025

Stocks in play: Roots Corp. - The Globe and Mail

Jun 13, 2025

Jun 11, 2025

Two Sigma Investments LP Cuts Stock Position in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jun 11, 2025

Jun 10, 2025

Cisco Powers AI-Ready Data Centers, From Hyperscale to Enterprise - The Globe and Mail

Jun 10, 2025

Jun 09, 2025

GoldMining Announces Closing of Flow-Through Financing and Commences Exploration at Yellowknife Gold Project - The Globe and Mail

Jun 09, 2025

Jun 05, 2025

Ballard announces 1.5 MW fuel cell engine order for Sierra Northern Railway - The Globe and Mail

Jun 05, 2025

Jun 04, 2025

Northern Trust Corp Grows Stock Holdings in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jun 04, 2025

Jun 03, 2025

CytomX Therapeutics jumps 54% after Q1 beat, prices $100M offering - MSN

Jun 03, 2025

Jun 03, 2025

Earnings call transcript: CytomX Therapeutics Q4 2024 reports strong revenue By Investing.com - Investing.com UK

Jun 03, 2025

Jun 02, 2025

BMO Lowers Fees on Asset Allocation ETFs to Deliver Greater Value to Investors - The Globe and Mail

Jun 02, 2025

May 31, 2025

Millennium Management LLC Grows Stake in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

May 31, 2025

May 31, 2025

CytomX stock soars to 52-week high, hits $2.66 By Investing.com - Investing.com South Africa

May 31, 2025

May 30, 2025

CytomX stock soars to 52-week high, hits $2.66 - Investing.com Australia

May 30, 2025

May 29, 2025

CytomX Therapeutics CEO Set for Jefferies Conference: Key Biologics Updates Coming - Stock Titan

May 29, 2025

May 29, 2025

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025

May 28, 2025

CytomX Shares Skyrocket: What’s Next? - StocksToTrade

May 28, 2025

May 20, 2025

CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) Shares Leap 225% Yet They're Still Not Telling The Full Story - simplywall.st

May 20, 2025

May 20, 2025

CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 20, 2025